Charles Schwab Investment Management Inc. Cuts Stock Position in 10x Genomics, Inc. (NASDAQ:TXG)
Charles Schwab Investment Management Inc. lessened its stake in 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 17.2% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 539,666 shares of the company’s stock after selling 111,916 shares during the quarter. Charles Schwab Investment Management […]
